Cargando…

Genomic Instability: A Stronger Prognostic Marker Than Proliferation for Early Stage Luminal Breast Carcinomas

BACKGROUND: The accurate prognosis definition to tailor treatment for early luminal invasive breast carcinoma patients remains challenging. MATERIALS AND METHODS: Two hundred fourteen early luminal breast carcinomas were genotyped with single nucleotide polymorphisms (SNPs) array to determine the nu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Vincent-Salomon, Anne, Benhamo, Vanessa, Gravier, Eléonore, Rigaill, Guillem, Gruel, Nadège, Robin, Stéphane, de Rycke, Yann, Mariani, Odette, Pierron, Gaëlle, Gentien, David, Reyal, Fabien, Cottu, Paul, Fourquet, Alain, Rouzier, Roman, Sastre-Garau, Xavier, Delattre, Olivier
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3797106/ https://www.ncbi.nlm.nih.gov/pubmed/24143191 http://dx.doi.org/10.1371/journal.pone.0076496

Ejemplares similares

Polarity gene alterations in pure invasive micropapillary carcinomas of the breast
por: Gruel, Nadège, et al.
Publicado: (2014)

LIN7A is a major determinant of cell-polarity defects in breast carcinomas
por: Gruel, Nadège, et al.
Publicado: (2016)

First description of a sporadic breast cancer in a woman with BRCA1 germline mutation
por: Curtit, Elsa, et al.
Publicado: (2015)

Estrogen-Receptor, Progesterone-Receptor and HER2 Status Determination in Invasive Breast Cancer. Concordance between Immuno-Histochemistry and MapQuant™ Microarray Based Assay
por: Mouttet, D., et al.
Publicado: (2016)

Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity
por: Vincent-Salomon, Anne, et al.
Publicado: (2007)

Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Correction: Respective Prognostic Value of Genomic Grade and Histological Proliferation Markers in Early Stage (pN0) Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2012)

Non-Sentinel Lymph Node Metastasis Prediction in Breast Cancer with Metastatic Sentinel Lymph Node: Impact of Molecular Subtypes Classification
por: Reyal, Fabien, et al.
Publicado: (2012)

TTK/hMPS1 Is an Attractive Therapeutic Target for Triple-Negative Breast Cancer
por: Maire, Virginie, et al.
Publicado: (2013)

The Molecular Subtype Classification Is a Determinant of Sentinel Node Positivity in Early Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2011)

Long-Term Prognostic Performance of Ki67 Rate in Early Stage, pT1-pT2, pN0, Invasive Breast Carcinoma
por: Reyal, Fabien, et al.
Publicado: (2013)

Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2015)

Time-varying effect and long-term survival analysis in breast cancer patients treated with neoadjuvant chemotherapy
por: Baulies, S, et al.
Publicado: (2015)

Correction: Beyond Axillary Lymph Node Metastasis, BMI and Menopausal Status Are Prognostic Determinants for Triple-Negative Breast Cancer Treated by Neoadjuvant Chemotherapy
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2016)

Oxidative stress promotes myofibroblast differentiation and tumour spreading
por: Toullec, Aurore, et al.
Publicado: (2010)

Histological grade concordance between diagnostic core biopsy and corresponding surgical specimen in HR-positive/HER2-negative breast carcinoma
por: Daveau, C, et al.
Publicado: (2014)

Molecular profiling of patient-derived breast cancer xenografts
por: Reyal, Fabien, et al.
Publicado: (2012)

Treatment Algorithms Based on Tumor Molecular Profiling: The Essence of Precision Medicine Trials
por: Le Tourneau, Christophe, et al.
Publicado: (2015)

8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis
por: Rodrigues-Ferreira, Sylvie, et al.
Publicado: (2009)

Transcriptome Analysis of Wnt3a-Treated Triple-Negative Breast Cancer Cells
por: Maubant, Sylvie, et al.
Publicado: (2015)

LRP8 is overexpressed in estrogen‐negative breast cancers and a potential target for these tumors
por: Maire, Virginie, et al.
Publicado: (2018)

Low expression of bcl-2 in Brca1-associated breast cancers
por: Freneaux, P, et al.
Publicado: (2000)

Are ipsilateral breast tumour invasive recurrences in young (⩽40 years) women more aggressive than their primary tumours?
por: Sigal-Zafrani, B, et al.
Publicado: (2007)

Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
por: Marty, Bérengère, et al.
Publicado: (2008)

Combination of Modern Radiotherapy and New Targeted Treatments for Breast Cancer Management
por: Beddok, Arnaud, et al.
Publicado: (2021)

Are we able to predict survival in ER-positive HER2-negative breast cancer? A comparison of web-based models
por: Laas, E, et al.
Publicado: (2015)

A subset of activated fibroblasts is associated with distant relapse in early luminal breast cancer
por: Bonneau, Claire, et al.
Publicado: (2020)

Luminal Progenitors Restrict Their Lineage Potential during Mammary Gland Development
por: Rodilla, Veronica, et al.
Publicado: (2015)

Prognostic Impact of Time to Ipsilateral Breast Tumor Recurrence after Breast Conserving Surgery
por: Gosset, Marie, et al.
Publicado: (2016)

A genomic and transcriptomic approach for a differential diagnosis between primary and secondary ovarian carcinomas in patients with a previous history of breast cancer
por: Meyniel, Jean-Philippe, et al.
Publicado: (2010)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy, Anne-Sophie, et al.
Publicado: (2018)

Performance evaluation of DNA copy number segmentation methods
por: Pierre-Jean, Morgane, et al.
Publicado: (2015)

Increased peak detection accuracy in over-dispersed ChIP-seq data with supervised segmentation models
por: Liehrmann, Arnaud, et al.
Publicado: (2021)

Pathological complete response and prognosis after neoadjuvant chemotherapy for HER2-positive breast cancers before and after trastuzumab era: results from a real-life cohort
por: Hamy-Petit, Anne-Sophie, et al.
Publicado: (2016)

Stronger synergies
por: Antonella Del Rosso
Publicado: (2012)

Medico-economic impact of MSKCC non-sentinel node prediction nomogram for ER-positive HER2-negative breast cancers
por: Bonsang-Kitzis, Hélène, et al.
Publicado: (2017)

On optimal multiple changepoint algorithms for large data
por: Maidstone, Robert, et al.
Publicado: (2016)

Fast tree aggregation for consensus hierarchical clustering
por: Hulot, Audrey, et al.
Publicado: (2020)

HPV DNA integration site as proof of the origin of ovarian metastasis from endocervical adenocarcinoma: three case reports
por: Arfi, Alexandra, et al.
Publicado: (2019)

Together We are Stronger
por: Zimmerman, Karen G., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_k939a4le8fcku06vvicpoj8ne5